Cargando…

Weight gain a risk factor for mortality in patients with acute kidney injury requiring continuous renal replacement therapy

Detalles Bibliográficos
Autores principales:	Maldonado Toral, C, Dono, L, Parra, A, Ramos, N, Albertos, R, Papiol, E, Pérez, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798230/ http://dx.doi.org/10.1186/2197-425X-3-S1-A466

Ejemplares similares

Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
por: Jung, HY, et al.
Publicado: (2014)

Determinants of renal recovery and mortality inpatients undergoing continuous renal replacement therapy in the ICU
por: Gleeson, PJ, et al.
Publicado: (2015)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Timing of continuous renal replacement therapies in acute kidney injury patients after cardiac surgery
por: Cardenas Campos, P, et al.
Publicado: (2015)

Amino acid adherence in continuous renal replacement therapies
por: Rodrigues, MG, et al.
Publicado: (2005)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

Continuous renal replacement therapy: are we getting the dose right?
por: Martin, S, et al.
Publicado: (2010)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Fluid balance and renal outcomes in patients requiring renal replacement therapy in the ICU
por: Silversides, JA, et al.
Publicado: (2013)

Community acquired vs hospital acquired acute kidney injury. mortality and timing of renal replacement therapy
por: Moreno-Gonzalez, G, et al.
Publicado: (2015)

Survivors of acute kidney injury requiring renal replacement therapy rarely receive follow-up: identification of an unmet need
por: Kirwan, CJ, et al.
Publicado: (2013)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Removal of inflammatory mediators by continuous renal replacement therapy in severe sepsis
por: Tomas, E, et al.
Publicado: (2009)

Continuous renal replacement therapy (CVVHD) for acute kidney injury in critical care: incidence and outcome across South West Wales
por: Brown, K, et al.
Publicado: (2014)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hybrid renal replacement techniques vs continuous haemodiafiltration in haemodynamically unstable patients
por: Marcelino, P, et al.
Publicado: (2006)

Micronutrient loss in renal replacement therapy for acute kidney injury
por: Oh, W, et al.
Publicado: (2015)

Long-term mortality of critically ill patients with acute renal failure requiring renal replacement therapy: a 5-year population-based cohort study
por: Christensen, S, et al.
Publicado: (2006)

Evaluation of microcirculation before and during continuous renal replacement therapy and the impact of dose prescription
por: Pipili, C, et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Protein content with parenteral nutrition in critical and hospitalized patients with continuous renal replacement therapies
por: Baez, AV, et al.
Publicado: (2015)

Outcome of patients treated with renal replacement therapy for acute kidney injury
por: Desegher, A, et al.
Publicado: (2006)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Infection in ICU patients with acute kidney injury treated with renal replacement therapy
por: Reynvoet, E, et al.
Publicado: (2006)

Association between type of anticoagulation and blood transfusion requirements during renal replacement therapy in the ICU
por: Iyer, A, et al.
Publicado: (2011)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience
por: Turani, F, et al.
Publicado: (2013)

Safety and efficacy of extracorporeal CO(2) removal combined with continuous renal replacement therapy in patients presenting both acute respiratory distress syndrome and acute kidney injury
por: Allardet-Servent, J, et al.
Publicado: (2015)

Longitudinal trajectory of acidosis and mortality in acute kidney injury requiring continuous renal replacement therapy
por: Lee, Jinwoo, et al.
Publicado: (2022)

Optimal dose of renal replacement therapy in acute kidney injury: a meta-analysis
por: Van Wert, RJ, et al.
Publicado: (2009)

Initiation of renal replacement therapy in patients with acute kidney injury and severe lactic acidosis
por: Vuylsteke, S, et al.
Publicado: (2008)

Long-term renal and survival outcomes in acute kidney injury patients receiving renal replacement therapy in intensive care
por: Elsayed, I, et al.
Publicado: (2015)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Systemic citrate load during continuous renal replacement therapy is not negligible and can be predicted using indirect methods
por: Zakharchenko, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nmpqjluan0vuh8ea665ajhedgu